Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner.
about
Survivin: a unique target for tumor therapy4-1BB Agonists: Multi-Potent Potentiators of Tumor ImmunityMicroRNA regulation and therapeutic targeting of survivin in cancer.CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression.SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccinesSA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancerThe tumor microenvironment: a pitch for multiple players.Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines.SA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines.Current challenges for cancer vaccine adjuvant development.Current perspectives of SA-4-1BBL in immune modulation during cancer.
P2860
Q26747332-08C71ED8-A6DB-4C3A-AF41-EABAF9B22B7FQ27012963-A52D58EA-3EDB-4B65-BDD0-105B00D75063Q34991312-E45E3982-41A4-49F5-B57B-88025B657227Q34996924-B3180837-90DE-40D2-8DBB-7929984182ADQ35980876-7A9AAF91-FC82-4A74-BF95-18B4134F9C3DQ36487245-B9746D2C-72B9-40E5-836E-896B0E5054A8Q36597325-E55AF3DF-29B7-4C8B-8536-E6BE3A2D38D9Q38101567-1B8D00ED-46B0-4ABD-9E7F-985C3A3DFA62Q40724926-D093221E-C743-43E6-ABEC-4B3B03F7C18FQ42186082-6329C282-8CA4-4E72-A926-0308A9E62D7DQ48160317-6ABA48F7-F445-4CE1-B5F2-56CB9E2F3A9DQ49875788-01096CF4-D6E8-4C77-9DC7-C7D7933F2DFD
P2860
Prime-boost vaccination with SA-4-1BBL costimulatory molecule and survivin eradicates lung carcinoma in CD8+ T and NK cell dependent manner.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prime-boost vaccination with S ...... and NK cell dependent manner.
@ast
Prime-boost vaccination with S ...... and NK cell dependent manner.
@en
type
label
Prime-boost vaccination with S ...... and NK cell dependent manner.
@ast
Prime-boost vaccination with S ...... and NK cell dependent manner.
@en
prefLabel
Prime-boost vaccination with S ...... and NK cell dependent manner.
@ast
Prime-boost vaccination with S ...... and NK cell dependent manner.
@en
P2093
P2860
P1433
P1476
Prime-boost vaccination with S ...... and NK cell dependent manner.
@en
P2093
Abhishek K Srivastava
Esma S Yolcu
Gunes Dinc
Haval Shirwan
Kathryn MacLeod
Rajesh K Sharma
Vahap Ulker
P2860
P304
P356
10.1371/JOURNAL.PONE.0048463
P407
P577
2012-11-08T00:00:00Z